超音波薬物送達システムが細菌バイオフィルムに対して高い効果を発揮(New ultrasound drug delivery system found to be highly effective against bacterial biofilms)

ad

2025-04-22 オックスフォード大学

オックスフォード大学の研究チームは、超音波で活性化されるナノ粒子を用いた新たな薬物送達システムを開発し、難治性のバイオフィルム感染症への高い効果を実証した。ナノ粒子が超音波で蒸気化することでバイオフィルムを物理的に破壊し、同時に抗生物質を感染部位に直接放出する。E. coliやMRSAなど10種の臨床株に対し、抗生物質の必要量を最大40分の1に削減。特に治療抵抗性の「休眠細胞」にも25分の1の濃度で効果を発揮した。臨床応用に向けた製造体制の整備が進められている。

<関連情報>

標的バイオフィルム薬物送達のための超音波トリガー・ナノスケール・システムによる抗菌薬の再利用 Repurposing antimicrobials with ultrasound-triggered nanoscale systems for targeted biofilm drug delivery

Victor Choi,Dario Carugo & Eleanor Stride
npj Antimicrobials and Resistance  Published:01 April 2025
DOI:https://doi.org/10.1038/s44259-025-00086-3

超音波薬物送達システムが細菌バイオフィルムに対して高い効果を発揮(New ultrasound drug delivery system found to be highly effective against bacterial biofilms)

Abstract

Chronic infections represent a major clinical challenge due to the enhanced antimicrobial tolerance of biofilm-dwelling bacteria. To address this challenge, an ultrasound-responsive nanoscale drug delivery platform (nanodroplets) is presented in this work, loaded with four different antimicrobial agents, capable of simultaneous biofilm disruption and targeted antimicrobial delivery. When loaded, a robust protective effect against clinically-derived MRSA and ESBL Gram-positive and Gram-negative planktonic isolates was shown in vitro. Upon application of therapeutic ultrasound, an average 7.6-fold, 44.4-fold, and 25.5-fold reduction was observed in the antibiotic concentrations compared to free drug required to reach the MBC, MBEC and complete persister eradication levels, respectively. Nanodroplets substantially altered subcellular distribution of encapsulated antimicrobials, enhancing accumulation of antimicrobials by 11.1-fold within the biofilm-residing bacteria’s cytoplasm compared to treatment with unencapsulated drugs. These findings illustrate the potential of this multifunctional platform to overcome the critical penetration and localization limitations of antimicrobials within biofilms, opening potential new avenues in the treatment of chronic clinical infections.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました